ATE196076T1 - Aerosol arzneiformulierungen - Google Patents

Aerosol arzneiformulierungen

Info

Publication number
ATE196076T1
ATE196076T1 AT91912299T AT91912299T ATE196076T1 AT E196076 T1 ATE196076 T1 AT E196076T1 AT 91912299 T AT91912299 T AT 91912299T AT 91912299 T AT91912299 T AT 91912299T AT E196076 T1 ATE196076 T1 AT E196076T1
Authority
AT
Austria
Prior art keywords
medicinal formulations
aerosol medicinal
aerosol
tetrafluoroethane
formulations
Prior art date
Application number
AT91912299T
Other languages
English (en)
Inventor
Keith A Johnson
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/649,405 external-priority patent/US5126123A/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ATE196076T1 publication Critical patent/ATE196076T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91912299T 1990-06-28 1991-06-27 Aerosol arzneiformulierungen ATE196076T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54543790A 1990-06-28 1990-06-28
US07/649,405 US5126123A (en) 1990-06-28 1991-02-01 Aerosol drug formulations
PCT/US1991/004715 WO1992000107A1 (en) 1990-06-28 1991-06-27 Aerosol drug formulations

Publications (1)

Publication Number Publication Date
ATE196076T1 true ATE196076T1 (de) 2000-09-15

Family

ID=27067939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912299T ATE196076T1 (de) 1990-06-28 1991-06-27 Aerosol arzneiformulierungen

Country Status (13)

Country Link
EP (1) EP0536250B1 (de)
JP (1) JP3056784B2 (de)
AT (1) ATE196076T1 (de)
AU (1) AU649702B2 (de)
CA (1) CA2083821A1 (de)
DE (1) DE69132407T2 (de)
ES (1) ES2151476T3 (de)
GB (1) GB2263064B (de)
IE (1) IE912246A1 (de)
IL (1) IL98639A0 (de)
NZ (1) NZ238749A (de)
PT (1) PT98105B (de)
WO (1) WO1992000107A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
US6503482B1 (en) 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
GB9202522D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3026841B2 (ja) 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
JPH09506097A (ja) * 1993-12-02 1997-06-17 アボツト・ラボラトリーズ 非ｃｆｃ噴射剤と共に用いるエアロゾル薬物調剤
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CN1279893C (zh) * 2001-08-03 2006-10-18 葛兰素集团有限公司 表面活性剂化合物及其用途
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
KR101348594B1 (ko) 2005-05-18 2014-01-07 노바르티스 아게 기관지 치료를 위한 밸브, 장치 및 방법
AU2006297289B2 (en) 2005-09-29 2013-03-21 Novartis Ag Antibiotic formulations, unit doses, kits, and methods
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
EP2350118B1 (de) 2008-09-19 2016-03-30 Nektar Therapeutics Kohlenhydratbasisierte polymere zur wirkstoffabgabe und konjugate davon
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
WO2019237151A1 (en) * 2018-06-13 2019-12-19 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
JPH05505824A (ja) * 1990-03-23 1993-08-26 ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー 所定投与量エアロゾル製剤の製造のための可溶性弗素界面活性剤の使用
FR2660297B1 (fr) * 1990-03-30 1992-06-12 Coflexip Dispositif de suspension et dispositif de liaison comportant un tel dispositif de suspension.
AU650463B2 (en) * 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations

Also Published As

Publication number Publication date
JPH05507935A (ja) 1993-11-11
DE69132407D1 (de) 2000-10-12
EP0536250B1 (de) 2000-09-06
AU8213591A (en) 1992-01-23
ES2151476T3 (es) 2001-01-01
GB2263064B (en) 1994-09-14
EP0536250A1 (de) 1993-04-14
IE912246A1 (en) 1992-01-01
CA2083821A1 (en) 1991-12-29
PT98105B (pt) 1998-11-30
AU649702B2 (en) 1994-06-02
NZ238749A (en) 1993-07-27
JP3056784B2 (ja) 2000-06-26
EP0536250A4 (en) 1993-06-16
PT98105A (pt) 1993-08-31
WO1992000107A1 (en) 1992-01-09
GB9223891D0 (en) 1993-04-21
DE69132407T2 (de) 2001-04-05
IL98639A0 (en) 1992-07-15
GB2263064A (en) 1993-07-14

Similar Documents

Publication Publication Date Title
DE69132407D1 (de) Aerosol arzneiformulierungen
EP0995434A3 (de) Medizinische Aerosolformulierungen
YU59192A (sh) Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
MX9203480A (es) Formulaciones medicinales en aereosol.
NZ238739A (en) Aerosol formulations comprising a powdered drug, a hydrofluorocarbon propellant and a perfluoroalkylsulphonamidoalkylphosphate surface-active agent
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
PH23529A (en) Drug-containing chlorofluorocarbon propellent formulations
MY131733A (en) Aerosol drug formulations
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
ES2061591T3 (es) Administracion intranasal de polipeptidos en forma pulverizada.
NL191508B (nl) Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamidederivaat, dat geschikt is voor gebruik in een zodanig preparaat.
WO1995017156A3 (en) Ethanol substitutes
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
EP0382411A3 (de) Abgabe von cytotoxischen Mitteln
ES2089357T3 (es) Formulacion medicinal en forma de aerosol.
CA2026990A1 (en) Anti-hiv agent
IS1914B (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
DE60017450D1 (de) Pharmazeutische formulierungen enthaltend salmeterol
FI920222A0 (fi) Doseringsmedel innefattande en jonofor.
GB2162746A (en) Antiacidotic medicinal agent
RU92016480A (ru) Аэрозольные композиции, содержащие лекарственный препарат